Larvol Delta - Evaluation-of-Safety-and-Tolerability-of-COR101-in-Hospitalized-Patients-With-Moderate-to-Severe-COVID19

COR-101 - Corat Therap, Dermapharm

http://clinicaltrials.gov/ct2/show/NCT04674566

Aug 18, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next